11:03 AM EDT, 07/09/2024 (MT Newswires) -- Humacyte ( HUMA ) signed an agreement to license Pluristyx's PluriBank induced Pluripotent Stem Cell line as starting materials to manufacture insulin-producing cells for its BioVascular Pancreas product candidate, Pluristyx said Tuesday. BioVascular Pancreas is under development as a potential treatment for type 1 diabetes. Financial terms of the agreement weren't disclosed. Pluristyx...

WASHINGTON, July 9 (Reuters) - The consolidation of pharmacies and health insurance companies through years of deal making has led to a handful of pharmacy benefit managers exercising outsized influence over prescription drug prices, the U.S. Federal Trade Commission said on Tuesday. Pharmacy benefit managers, or PBMs, act as middlemen between drug companies and consumers. They negotiate volume discounts and...

(Reuters) - Boeing ( BA ) said on Tuesday it delivered more commercial jets in June than in any other month this year, but the total of 44 planes represented a 27% drop on an annual basis amid a whirlwind of legal and production challenges. The company has pledged to expand production by the end of the year, after wrestling...

VIENNA, July 9 (Reuters) - Austrian prosecutors said they will bring criminal charges against two men accused of selling fake versions of Novo Nordisk's diabetes drug Ozempic, resulting in bodily harm in three women. The defendants had acted as traders and sold 225 bogus injection pens falsely labelled as Ozempic for 205 euros ($222) apiece to a plastic surgeon in...